Does treatment with bisphosphonates protect against fractures in real life? The HUNT study, Norway

被引：0
|
作者：
M. Hoff
E. Skovlund
H. E. Meyer
A. Langhammer
A. J. Søgaard
U. Syversen
K. Holvik
B. Abrahamsen
B. Schei
机构：
[1] Norwegian University of Science and Technology,Department of Neuromedicine and Movement Science
[2] NTNU,Department of Public Health and Nursing
[3] Norwegian University of Science and Technology,Department of Rheumatology
[4] NTNU,Department of Community Medicine and Global Health
[5] St. Olavs hospital,HUNT Research Centre, Department of Public Health and Nursing
[6] Trondheim University Hospital,Levanger Hospital
[7] Norwegian Institute of Public Health,Department of Endocrinology
[8] University of Oslo,Department of Clinical and Molecular Medicine
[9] Norwegian University of Science and Technology,Department of Medicine
[10] NTNU,Odense Patient Data Explorative Network, Institute of Clinical Research
[11] Nord-Trøndelag Hospital Trust,Department of Gynecology
[12] St. Olavs hospital,undefined
[13] Trondheim University Hospital,undefined
[14] Norwegian University of Science and Technology,undefined
[15] NTNU,undefined
[16] Holbæk Hospital,undefined
[17] University of Southern Denmark,undefined
[18] St. Olavs hospital,undefined
[19] Trondheim University Hospital,undefined
来源：
Osteoporosis International | 2021年 / 32卷
关键词：
Anti-osteoporotic drugs; Cohort study; Fractures; General population studies; HUNT; Osteoporosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1395 / 1404
页数：9
相关论文
共 50 条
  • [21] Does hemophilia protect against atherosclerosis? A case-control study
    Bilora, F
    Zanon, E
    Petrobelli, F
    Cavraro, M
    Prandoni, P
    Pagnan, A
    Girolami, A
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2006, 12 (02) : 193 - 198
  • [22] Does treatment affect real life outcomes in schizophrenia?
    Fleischhacker, WW
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S315 - S315
  • [23] Does systemic antiviral treatment of herpes zoster protect against cardiovascular events?
    Drerup, Katharina Antonia
    Glaeser, Regine
    DERMATOLOGIE, 2022, 73 (09): : 753 - 755
  • [24] Preceding surfactant treatment does not protect against lung volutrauma at birth † 1518
    J Ingimarsson
    L J Björklund
    T Curstedt
    A Larsson
    B Robertson
    N W Svenningsen
    O Werner
    Pediatric Research, 1997, 41 (Suppl 4) : 255 - 255
  • [25] Treatment with low-dose haloperidol does not protect against tardive dyskinesia
    Oosthuizen, P
    Emsley, RA
    Maritz, JS
    Turner, J
    Keyter, N
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 364 - 364
  • [26] SPINE OSTEOARTHRITIS DOES NOT PROTECT AGAINST INCIDENT VERTEBRAL FRACTURES DESPITE HIGHER LUMBAR SPINE BMD
    Betancourt, M. C. Castano
    Rivadeneira, F.
    Hofman, A.
    Bierma-Zeinstra, S.
    Pols, H.
    Uitterlinden, A. G.
    Van Meurs, J.
    OSTEOARTHRITIS AND CARTILAGE, 2010, 18 : S43 - S43
  • [27] Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study
    Goulden, R.
    Riise, T.
    Myhr, K. -M.
    Pugliatti, M.
    Wolfson, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (01) : 168 - 174
  • [28] Does a clinical study reflect real-life and real-life costs
    Juhl, HH
    Hvenegaard, A
    Schmidt, VM
    Habicht, A
    VALUE IN HEALTH, 2005, 8 (03) : 373 - 374
  • [29] Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: The risedronate and alendronate (REAL) cohort study
    Silverman, S. L.
    Watts, N. B.
    Delmas, P. D.
    Lange, J. L.
    Lindsay, R.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 (01) : 25 - 34
  • [30] Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: The risedronate and alendronate (REAL) cohort study
    S. L. Silverman
    N. B. Watts
    P. D. Delmas
    J. L. Lange
    R. Lindsay
    Osteoporosis International, 2007, 18 : 25 - 34
12345